Analystreport

Tcr2 Therapeutics Inc (NASDAQ: TCRR) is now covered by analysts at Roth Capital. They set a "neutral" rating on the stock.

TCR2 Therapeutics Inc.  (TCRR) 
Last tcr2 therapeutics inc. earnings: 11/12 07:00 am Check Earnings Report